Lorne Clarke, MD
Professor, Department of Medical Genetics
University of British Columbia
Simon Ibell
Mucopolysaccharidosis type II (or MPS II) is a progressively debilitating disorder primarily diagnosed in males approximately 2 years of age. For researchers across Canada, providing a higher standard of living for patients of disease is always a priority. Raising awareness of rare diseases like MPS II is vital for early recognition & diagnosis; for the individual, it can be a matter of life and death.
